Cost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: It is time for evidence based economic evaluations

J Med Econ. 2021 May 12:1. doi: 10.1080/13696998.2021.1929259. Online ahead of print.NO ABSTRACTPMID:33979234 | DOI:10.1080/13696998.2021.1929259

Source: Journal of Medical Economics - May 12, 2021 Category: Health Management Authors: Alois Gratwohl Source Type: research